NMD4C steering committee member Dr. Jim Dowling appointed Chair of the executive committee of TREAT-NMD

NMD4C steering committee member Dr. Jim Dowling appointed Chair of the executive committee of TREAT-NMD

The NMD4C would like to congratulate our Steering Committee member Dr. Jim Dowling on his appointment as Chair of the executive committee of TREAT-NMD!

 

Along with his duties as Chair, Dr. Dowling also serves as a member of the TREAT-NMD Advisory Committee for Therapeutics.

TREAT-NMD is a network for the neuromuscular field that provides an infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Since its launch in January 2007 the network’s focus has been on the development of tools that industry, clinicians and scientists need to bring novel therapeutic approaches through preclinical development and into the clinic, and on establishing best-practice care for neuromuscular patients worldwide.

TREAT-NMD would like to recognise the valuable work in the neuromuscular field that many organizations, institutions, companies, and individuals are undertaking with an invitation to become a member of the new TREAT-NMD Alliance.

Become a member of TREAT-NMD here!

Find TREAT-NMD on twitter @treat_nmd

NMD4C steering committee member Dr. Jim Dowling appointed Chair of the executive committee of TREAT-NMD

Read next...

New Milestone: 100 Canadian Neuromuscular Clinical Trials now listed in our database!

New Milestone: 100 Canadian Neuromuscular Clinical Trials now listed in our database!

We are happy to announce that our Neuromuscular Clinical Trial Database, developed in partnership with Muscular Dystrophy Canada, has officially reached 100 Canadian clinical trial listings!

BSTC Icon - Light Background

New Standard Operating Procedure: Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers

We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers”, developed by our BSTC members Dr. Sean Ng and Magda Lensinski.

Post Event - 2026 Clinical Summer School v2

NMD4C Hosts 2nd Annual Clinical Summer School at the University of Calgary!

On 24 September 2026, our second annual NMD4C Clinical Summer School brought together 25 neuromuscular fellows from across Canada to the University of Calgary for a day of hands-on learning, discussion, connection, and collaboration.